Table 5.

Logistic Regression, adjusting for age and stage, of each diagnosis and treatment covariates to Predict presence of up-to-date medical records, adjusted for age and stage (n=394)

		Counts (%)	OR (95% CI)	p-valuea
Total Duration of Treatment		394	1.001(1.00, 1.002)	0.0003b
Initial Intent of Therapy	None	38 (9.6)	ref	<0.0001b
	Neoadjuvant	166 (42.1)	12.1 (1.6, 92.5)	0.0695
	Adjuvant	104 (26.4)	28.6 (3.7, 219)	<0.0001
	Palliative	70 (17.8)	3.2 (0.36, 29.3)	0.1011
	Other	16 (4.1)	13.9 (1.4, 136)	0.1708
Hormone Status Report	Known	66 (16.8)	ref	<0.0001b
	Never Requested	214 (54.3)	0.36 (0.19, 0.7)	<0.0001
	Results Not Returned	114 (28.9)	0.09 (0.05, 0.18)	0.5432
Type of Surgery First Performed	None	172 (43.7)	ref	<0.0001b
	Mastectomy	124 (31.5)	9.6 (4.7, 19.6)	<0.0001
	Lumpectomy	98 (24.9)	4.7 (2.1, 10.5)	0.1877
All Surgeries Received	None	172 (43.7)	ref	<0.0001b
	One or More Mastectomy	123 (31.2)	9.4 (4.6, 19.2)	0.0006
	One or More Lumpectomy	83 (21.1)	4.3 (1.9, 9.8)	0.8984
	Combination	16 (4.1)	9.4 (2.8, 31.5)	0.0621
Sufficient Therapy Received	No Therapy Received	108 (27.4)	ref	<0.0001b
	Unknown	9 (2.3)	12.2 (1.0, 144)	0.1184
	No	108 (27.4)	1.9 (0.2, 16.7)	0.0551
	Yes	242 (61.4)	19.3 (2.6, 146)	<0.0001
Total Barriers Encountered	None	165 (41.9)	ref	<0.0001b
	Unknown	35 (8.9)	82.2 (24.1, 280)	<0.0001
	Financial as a Component or by Itself	34 (8.6)	20.3 (6.2, 66.7)	0.2092
	All Physical Conditions without a Financial Component	160 (40.6)	19.3 (7.1, 52.4)	0.1247
Eventualc Changes in Treatment Intent	None	299 (75.9)	ref	<0.0001b
	Adjuvant	48 (12.2)	6.7 (3.4, 13.2)	<0.0001
	Palliative	47 (11.9)	0.9 (0.4, 2.3)	0.0279

^aP-values are derived from Wald Chi-Square parameter estimates unless otherwise specified

^bOverall Type III Analysis of Effects

^cAs Individuals may undergo more than one change in therapy goal, this accounts for the last change made